Barcha huquqlar himoyalangan.
0.00
0.00 (0.00%)
There is no data to display
SCOTTSDALE, Ariz., Feb. 24, 2026 /PRNewswire/ -- Software & Services revenue grows 40% to $343 million Net income of $3 million supports non-GAAP net income of $178 million and Adjusted EBITDA of $206 million Company establishes 2026 outlook of 27% to 30% revenue growth and a 25.5% Adjusted EBITDA margin Introduces new 2028 targets of $6 billion in annual revenue and 28% Adjusted EBITDA margin Fellow shareholders, Axon completed another record year in pursuit of our mission to protect life.
TEL AVIV, Israel , Dec. 3, 2025 /PRNewswire/ -- Axon Vision (TASE: AXN) announced today a strategic cooperation agreement with Leonardo DRS to pursue opportunities in advanced situational awareness, lethality, and survivability, with special emphasis on Counter-UAS (C-UAS) solutions in the U.S. defense market. The partnership is expected to address a critical demand for on-platform AI-driven capabilities that support force protection and platform modernization.
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a pioneer in non-invasive robotic brain surgery, today announced that its award-winning ZAP-Axon® Radiosurgery Planning System has received both U.S. FDA 510(k) clearance and European CE certification. These key regulatory milestones authorize clinical use of ZAP-Axon throughout the United States and European Union, marking a significant advance in the evolution of world-class radiosurgery planning. Dedicated exclusively to crania.
Acquisition brings next-generation, cloud-native 911 technology into the Axon ecosystem, uniting connected devices, real-time communications, and digital evidence from call to courtroom. SCOTTSDALE, Ariz.
